QUMAS announced today that it has signed a major contract with a leading Fortune 500 pharmaceutical company.
After an extensive evaluation, the Fortune 500 Company choose the QUMAS Regulatory, Quality and Compliance Management Solution to manage content and processes across the company, as well as enabling controlled and compliant collaboration with an extended network of partners across the supply chain.
The QUMAS Solution will replace a legacy Documentum document management system and will be rolled out to over 30,000 employees and 7,000 users across various partners, contractors and suppliers.
The QUMAS Quality and Compliance Management system enables life sciences firms to achieve regulatory compliance across the organization, accelerate the delivery of new products, reduce costs and ensure consistency of quality, information and processes.
“Life Sciences firms are relying on an extended ecosystem of service providers to help with drug discovery, manufacturing, sales & marketing and distribution,” stated Kevin O’Leary, CEO of QUMAS. “Our Compliance Solutions allow firms to control and exchange sensitive information and tasks inside and outside the walls of an organization, in a compliant manner that also protects their intellectual property.”
QUMAS is the leader in Enterprise Regulatory, Quality and Compliance Solutions with more than 270 global customer deployments and two decades of experience helping companies in highly regulated industries. QUMAS is a Microsoft Gold Partner, and provides the QUMAS Compliance Platform on SharePoint 2010, Documentum, Oracle or SQL. For more information, visit www.qumas.com.